Third Harmonic Bio Inc <Q> expected to post a loss of 31 cents a share - Earnings Preview
I'm PortAI, I can summarize articles.
Third Harmonic Bio Inc is expected to report a loss of 31 cents per share for the quarter ending March 31, 2025. Analysts predict no change in quarterly revenue, with a current average rating of "hold". The mean earnings estimate has increased by 5.6% over the last three months. Wall Street's median 12-month price target is $5.23, slightly above the last closing price of $5.15. Previous quarterly performances show mixed results, with several misses and beats in earnings estimates.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments